Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25A | P30304 | 4/20 | 0.76 |
| ▸ | POLA1 | P09884 | 1/20 | 0.74 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.74 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.74 |
| ▸ | INPP5D | Q92835 | 1/20 | 0.72 |
| ▸ | ST6GAL1 | P15907 | 1/20 | 0.62 |
| ▸ | HPSE | Q9Y251 | 10/20 | 0.61 |
| ▸ | FGF1 | P05230 | 7/20 | 0.61 |
| ▸ | FGF2 | P09038 | 6/20 | 0.60 |
| ▸ | USP2 | O75604 | 1/20 | 0.59 |
| ▸ | VDR | P11473 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bicarbonate SCHEMBL10868797 | 0.95 | CDC25A (0.80) | CDC25APOLA1CYP2D6CYP2C19INPP5D | |
| SCHEMBL14552062 | 0.94 | CYP2D6 (0.76) | CDC25APOLA1CYP2D6CYP2C19INPP5D | |
| SCHEMBL12590990 | 0.92 | CDC25A (0.74) | CDC25APOLA1CYP2D6CYP2C19INPP5D | |
| SCHEMBL4737651 | 0.92 | CDC25A (0.74) | CDC25APOLA1CYP2D6CYP2C19INPP5D | |
| SCHEMBL16248053 | 0.92 | CDC25A (0.74) | CDC25APOLA1CYP2D6CYP2C19INPP5D | |
| SCHEMBL23282987 | 0.92 | CDC25A (0.74) | CDC25APOLA1CYP2D6CYP2C19INPP5D | |
| SCHEMBL17875190 | 0.92 | CDC25A (0.74) | CDC25APOLA1CYP2D6CYP2C19INPP5D | |
| SCHEMBL10017479 | 0.92 | CDC25A (0.74) | CDC25APOLA1CYP2D6CYP2C19INPP5D | |
| SCHEMBL19722006 | 0.92 | CDC25A (0.74) | CDC25APOLA1CYP2D6CYP2C19INPP5D | |
| SCHEMBL19009192 | 0.92 | CDC25A (0.74) | CDC25APOLA1CYP2D6CYP2C19INPP5D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 625 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-7300408-A | — | — | None | — | — | JP | disclosed |
| CN-116456956-B | Solid cosmetic material | SHISEIDO CO.,LTD. (JP) | 2026-05-26 | — | — | CN | disclosed |
| EP-4736836-A1 | TWO-LAYER SEPARATION TYPE COMPOSITION | Kao Corporation (JP) | 2026-05-06 | — | — | EP | disclosed |
| EP-4122443-B1 | COSMETIC COMPOSITION WITH SILICONE-MODIFIED POLYSACCHARIDE | SHINETSU CHEMICAL CO (JP) | 2026-05-06 | — | — | EP | disclosed |
| US-20260098007-A1 | Compounds and Their Use in Filtering Ultraviolet and/or High-Energy Visible Light | SOLIOME INC (US) | 2026-04-09 | — | — | US | disclosed |
| US-20260076892-A1 | GEL COMPOSITION AND OIL-IN-WATER COMPOSITION | SHISEIDO COMPANY, LTD. (JP) | 2026-03-19 | — | — | US | disclosed |
| EP-4710926-A1 | TOPICAL COMPOSITION | Api Co., Ltd. (JP) | 2026-03-18 | — | — | EP | disclosed |
| US-12569426-B2 | Topical skin preparation composition | KAO CORPORATION (JP) | 2026-03-10 | — | — | US | disclosed |
| US-12569427-B2 | Makeup application method | KAO CORPORATION (JP) | 2026-03-10 | — | — | US | disclosed |
| US-12564549-B2 | Cleanser composition | SHISEIDO COMPANY, LTD. (JP) | 2026-03-03 | — | — | US | disclosed |
| EP-0361928-B1 | Emulsified composition | SHISEIDO CO LTD (JP) | 1994-04-27 | — | — | EP | disclosed |
| US-5223244-A | Undissolved composite powder with polymer core and attached sheath, non-chlorofluorocarbon propellant | SHISEIDO COMPANY, LTD. (JP) | 1993-06-29 | — | — | US | disclosed |
| US-5162377-A | Cosmetics, Drugs | SHISEIDO COMPANY, LTD. (JP) | 1992-11-10 | — | — | US | disclosed |
| US-5120716-A | Drug, anionic surfactant and either amphoteric nonionic or semi-polar surfactant containing nitrogen | SHISEIDO COMPANY LTD. (JP) | 1992-06-09 | — | — | US | disclosed |
| US-5098606-A | Lipids, sugars, water and nonionic surfactants for drugs | SHISEIDO COMPANY LTD. (JP) | 1992-03-24 | — | — | US | disclosed |
| EP-0429248-A2 | Emulsified composition | SHISEIDO COMPANY LIMITED (JP) | 1991-05-29 | — | — | EP | disclosed |
| EP-0361928-A2 | Emulsified composition | SHISEIDO COMPANY LIMITED (JP) | 1990-04-04 | — | — | EP | disclosed |
| EP-0349150-A2 | Transparent compostition | SHISEIDO COMPANY LIMITED (JP) | 1990-01-03 | — | — | EP | disclosed |
| EP-0303713-A1 | PERCUTANEOUS ABSORPTION PROMOTER AND DERMATOLOGIC PREPARATION FOR EXTERNAL USE | SHISEIDO COMPANY LIMITED (JP) | 1989-02-22 | — | — | EP | disclosed |
| US-4254104-A | COMPRISING ADDING A NONIONIC SURFACTANT AND A WATER SOLUBLE SOLVENT TO AN OIL | SHISEIDO CO., LTD. (JP) | 1981-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260076892-A1 | GEL COMPOSITION AND OIL-IN-WATER COMPOSITION | SGMS1, SGMS2, CETP | CDC25A 2870/4885POLA1 977/4885CYP2D6 3298/4885 |
| US-12564549-B2 | Cleanser composition | LIPA, SGMS1, SGMS2 | CDC25A 1670/4885POLA1 705/4885CYP2D6 4116/4885 |
| US-20260098007-A1 | Compounds and Their Use in Filtering Ultraviolet and/or High-Energy Visible Light | UGT8, UGT1A3, FUT5 | CDC25A 2519/4885POLA1 1526/4885CYP2D6 1376/4885 |
| US-12569426-B2 | Topical skin preparation composition | KRT18, CUTA, TMSB10 | CDC25A 2358/4885POLA1 1627/4885CYP2D6 4526/4885 |
| US-12569427-B2 | Makeup application method | LMNB1, LMNB2, PFN1 | CDC25A 1205/4885POLA1 610/4885CYP2D6 3489/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.